Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Options Action: Traders bearish on Eli Lilly ahead of earnings
06:06pm, Monday, 07'th Aug 2023
Mike Khouw, Optimize Advisors president, joins CNBC's Melissa Lee and the Options Action traders to talk Eli Lilly.
Nektar Therapeutics sues Eli Lilly over autoimmune disease treatment
11:30am, Monday, 07'th Aug 2023
Nektar Therapeutics on Monday sued Eli Lilly , accusing the drugmaker of undermining the prospects for Rezpeg, which Nektar was developing as a treatment for various autoimmune diseases.
Eli Lilly expected to deliver a solid if unspectacular earnings update
10:01am, Monday, 07'th Aug 2023
Eli Lilly and Company is slated to unveil its second-quarter 2023 results on Tuesday (August), prior to the market opening, with Wall Street expecting earnings of $1.98 a share. That's up around 9%
Nektar rallies after releasing new data for rezpeg after Eli Lilly got it wrong
08:10am, Monday, 07'th Aug 2023
Nektar Therapeutics (NASDAQ:NKTR) shares rallied more than 15% in Monday pre-market trading after the company released new efficacy data from phase 1b studies from rezpegaldesleukin (rezpeg) after th
Nektar Therapeutics' stock NKTR, +3.14% jumped 12.7% in premarket trade Monday, after the company said that efficacy data previously generated by its former partner Eli Lilly & Co. LLY, +0.07% for its
2 Top Biotech Stocks to Buy in August
09:15am, Sunday, 06'th Aug 2023
Vertex's business should get a major boost in the coming years with new approvals. Eli Lilly's expanding portfolio of new products will help it maintain its recent momentum.
Eli Lilly reports positive results in trial of tretment for non-small cell lung cancer
08:01am, Friday, 04'th Aug 2023
Eli Lilly & Co. LLY, -1.17% said Friday a late-stage trial of a treatment for a type of non-small cell lung cancer met its main goal. The Phase 3 trial dubbed Libretto-431 showed a statistically signi
Beat the Dow Jones With This Unstoppable Dividend Stock
07:45am, Friday, 04'th Aug 2023
Eli Lilly's current portfolio looks competitive when excluding its covid products. The company's pipeline of potential products is highly promising, too.
The issue with Eli Lilly is the very competitive drug market, says Short Hills Partners' Weiss
02:17pm, Wednesday, 02'nd Aug 2023
CNBC's 'Halftime Report' Investment Committee discusses Eli Lilly's current valuation relative to revenue growth, and the obesity drug market.
Better Alzheimer's Drug Stock: Eli Lilly vs. Biogen
07:45am, Monday, 31'st Jul 2023
Biogen and Eli Lilly are two major competitors in the field of Alzheimer's disease. Eli Lilly's medicine appears to slow the rate of cognitive decline more than Biogen's.
AI Stock Marvell And Eli Lilly Lead 5 Names Near Buy Points As S&P 500 Rallies On
11:12am, Saturday, 29'th Jul 2023
Top AI stock Marvell Technology and Eli Lilly lead this weekend's watch list of five stocks near buy points as the new S&P 500 bull market revs back up.
2 Healthcare Stocks That Could Make You Richer
09:30am, Saturday, 29'th Jul 2023
As a producer of medicines for animals, Zoetis benefits from increased spending on pets. Thanks to a strong product line, Eli Lilly briefly ranked as the biggest pharma company this year.
Eli Lilly: There Is No Logic To This Over Optimism
04:00pm, Friday, 28'th Jul 2023
Mounjaro may rake in $25B of annualized sales by 2026, exceeding ABBV's Humira. This naturally explains Mr. Market's optimism surrounding the LLY's stock thus far. The same has been witnessed with NVO
Eli Lilly Says Weight-Loss Drug Helps Patients Lose 26% of Their Weight, More Than Rivals
05:50pm, Thursday, 27'th Jul 2023
Eli Lilly said that two Phase 3 trials of its weight-loss drug tirzepatide showed patients lost 26.6% of their body weight on average, more than competitors.
7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes
09:42am, Thursday, 27'th Jul 2023
Healthcare continues to be a major industry and economic driver around the world. According to the American Medical Association, spending on healthcare in the U.S. totals more than $4 trillion each ye
